Literature DB >> 7987862

Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.

I Vollenweider1, R Moser, P Groscurth.   

Abstract

A series of 62 lymphokine-activated killer cell (LAK) cultures from 44 different donors was investigated for the distribution of various CD markers during a cultivation period of 3 weeks. Great differences in the phenotypic pattern were found between different donors, but similar changes of the subset pattern of various donors allowed a classification of the LAK cultures into four distinct LAK types. LAK type 1 was characterised by low numbers of CD3+ cells and high values for CD56+ cells. In LAK type 2 cultures gamma/delta TCR+ cells extensively proliferated, whereas in LAK type 3 cultures the CD57 and CD8 values increased considerably. LAK type 4 cultures did not show any of these characteristics. The resulting phenotype of a LAK culture was donor-specific, as LAK cultures established from the same peripheral blood mononuclear cells (PBMC), fresh or after cryopreservation, or from PBMC obtained from the same donor at different venous punctures, always developed the same phenotype. A clear correlation between phenotype and killing activity could only be found for LAK type 1 cultures, which always developed high lytic activity. Long-term IL-2 stimulation induced high levels of perforin-positive cells in LAK cultures but the perforin content did not correlate with the cytotoxicity. The transcription pattern for various cytokines only varied slightly between the cultures. Messenger RNA for granulocyte/macrophage- colony-stimulating factor, interferon gamma, tumour necrosis factor alpha, interleukin-4 (IL-4) and IL-5 were found in almost all cultures during the entire cultivation period, whereas mRNA for IL-2 was never detected. Most variations in the transcription pattern were observed for IL-6 and IL-7. However, no correlation could be found between the endogenous cytokine production and the phenotype or lytic activity of the LAK cultures. Further studies are required to determine the factors that cause lymphocyte subsets from a specific donor to proliferate preferentially under long-term IL-2 stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987862     DOI: 10.1007/BF01519983

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  32 in total

1.  Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2.

Authors:  E J Kovacs; S K Beckner; D L Longo; L Varesio; H A Young
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

2.  Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells.

Authors:  W L Crump; L B Owen-Schaub; E A Grimm
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

3.  Heterogeneous binding and killing behaviour of human gamma/delta-TCR+ lymphokine-activated killer cells against K562 and Daudi cells.

Authors:  I Vollenweider; E Vrbka; W Fierz; P Groscurth
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

4.  Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.

Authors:  E Roussel; J M Gerrard; A H Greenberg
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoring.

Authors:  F Farace; M Pallardy; E Angevin; T Hercend; B Escudier; F Triebel
Journal:  Int J Cancer       Date:  1994-06-15       Impact factor: 7.396

6.  Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells.

Authors:  I Kaur; S D Voss; R S Gupta; K Schell; P Fisch; P M Sondel
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

7.  Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.

Authors:  P R Fuchshuber; E Lotzová; R E Pollock
Journal:  Lymphokine Cytokine Res       Date:  1991-04

8.  Selective activation of resting human gamma delta T lymphocytes by interleukin-2.

Authors:  J Kjeldsen-Kragh; A J Quayle; B S Skålhegg; M Sioud; O Førre
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

9.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

10.  Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression.

Authors:  K A Saraya; F R Balkwill
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  2 in total

1.  Human dendritic cells process and present Listeria antigens for in vitro priming of autologous CD4+ T lymphocytes.

Authors:  Elisabeth Eppler; Michael Walch; Sonja Latinovic-Golic; Claudia Dumrese; Luis Filgueira; Peter Groscurth
Journal:  Histochem Cell Biol       Date:  2005-04-06       Impact factor: 4.304

2.  Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes.

Authors:  Sonja Latinovic-Golic; Michael Walch; Hanna Sundstrom; Claudia Dumrese; Peter Groscurth; Urs Ziegler
Journal:  BMC Immunol       Date:  2007-06-27       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.